95 related articles for article (PubMed ID: 15182249)
41. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.
Watts C
Nat Immunol; 2004 Jul; 5(7):685-92. PubMed ID: 15224094
[TBL] [Abstract][Full Text] [Related]
42. Intracellular CD154 expression reflects antigen-specific CD8+ t cells but shows less sensitivity than intracellular cytokine and MHC tetramer staining.
Han YW; Aleyas AG; George JA; Yoon HA; Lee JH; Kim BS; Eo SK
J Microbiol Biotechnol; 2007 Dec; 17(12):1955-64. PubMed ID: 18167442
[TBL] [Abstract][Full Text] [Related]
43. The labyrinth unfolds: architectural rearrangements of the endolysosomal system in antigen-presenting cells.
Perrin P; Jongsma ML; Neefjes J; Berlin I
Curr Opin Immunol; 2019 Jun; 58():1-8. PubMed ID: 30738283
[TBL] [Abstract][Full Text] [Related]
44. Formation and kinetics of MHC class I-ovalbumin peptide complexes on immature and mature murine dendritic cells.
Kukutsch NA; Rossner S; Austyn JM; Schuler G; Lutz MB
J Invest Dermatol; 2000 Sep; 115(3):449-53. PubMed ID: 10951282
[TBL] [Abstract][Full Text] [Related]
45. Tubulation of class II MHC compartments is microtubule dependent and involves multiple endolysosomal membrane proteins in primary dendritic cells.
Vyas JM; Kim YM; Artavanis-Tsakonas K; Love JC; Van der Veen AG; Ploegh HL
J Immunol; 2007 Jun; 178(11):7199-210. PubMed ID: 17513769
[TBL] [Abstract][Full Text] [Related]
46. Cyclosporin A and tacrolimus, but not rapamycin, inhibit MHC-restricted antigen presentation pathways in dendritic cells.
Lee YR; Yang IH; Lee YH; Im SA; Song S; Li H; Han K; Kim K; Eo SK; Lee CK
Blood; 2005 May; 105(10):3951-5. PubMed ID: 15657176
[TBL] [Abstract][Full Text] [Related]
47. MHC class I presentation of live and heat-inactivated Sendai virus antigen in T2Kb cells depends on an intracellular compartment with endosomal characteristics.
Liu T; Zhou X; Abdel-Motal UM; Ljunggren HG; Jondal M
Scand J Immunol; 1997 May; 45(5):527-33. PubMed ID: 9160098
[TBL] [Abstract][Full Text] [Related]
48. Insulin-regulated aminopeptidase and its compartment in dendritic cells.
Saveanu L; Babdor J; Lawand M; van Endert P
Mol Immunol; 2013 Sep; 55(2):153-5. PubMed ID: 23123036
[TBL] [Abstract][Full Text] [Related]
49. Endosomal/lysosomal retention and degradation of major histocompatibility complex class I molecules is induced by myxoma virus.
Zúñiga MC; Wang H; Barry M; McFadden G
Virology; 1999 Sep; 261(2):180-92. PubMed ID: 10497104
[TBL] [Abstract][Full Text] [Related]
50. Aldehyde-mannan antigen complexes target the MHC class I antigen-presentation pathway.
Apostolopoulos V; Pietersz GA; Gordon S; Martinez-Pomares L; McKenzie IF
Eur J Immunol; 2000 Jun; 30(6):1714-23. PubMed ID: 10898509
[TBL] [Abstract][Full Text] [Related]
51. Endosomal processing for antigen presentation mediated by CD1 and Class I major histocompatibility complex: roads to display or destruction.
Boes M; Stoppelenburg AJ; Sillé FC
Immunology; 2009 Jun; 127(2):163-70. PubMed ID: 19476512
[TBL] [Abstract][Full Text] [Related]
52. Kinetics and intracellular pathways required for major histocompatibility complex II-peptide loading and surface expression of a fluorescent hapten-protein conjugate in murine macrophage.
Weaver DJ; Voss EW
Immunology; 1999 Apr; 96(4):557-68. PubMed ID: 10233742
[TBL] [Abstract][Full Text] [Related]
53. Transfer of GRP94(Gp96)-associated peptides onto endosomal MHC class I molecules.
Berwin B; Rosser MF; Brinker KG; Nicchitta CV
Traffic; 2002 May; 3(5):358-66. PubMed ID: 11967129
[TBL] [Abstract][Full Text] [Related]
54. A SIINFEKL-Based System to Measure MHC Class I Antigen Presentation Efficiency and Kinetics.
Dersh D; Yewdell JW; Wei J
Methods Mol Biol; 2019; 1988():109-122. PubMed ID: 31147936
[TBL] [Abstract][Full Text] [Related]
55. Protein Transduction Domain Mimics Facilitate Rapid Antigen Delivery into Monocytes.
Backlund CM; Parhamifar L; Minter L; Tew GN; Andresen TL
Mol Pharm; 2019 Jun; 16(6):2462-2469. PubMed ID: 31095395
[TBL] [Abstract][Full Text] [Related]
56. A simple methodology to assess endolysosomal protease activity involved in antigen processing in human primary cells.
Vaithilingam A; Lai NY; Duong E; Boucau J; Xu Y; Shimada M; Gandhi M; Le Gall S
BMC Cell Biol; 2013 Aug; 14():35. PubMed ID: 23937268
[TBL] [Abstract][Full Text] [Related]
57. Endolysosomal proteases and their inhibitors in immunity.
Bird PI; Trapani JA; Villadangos JA
Nat Rev Immunol; 2009 Dec; 9(12):871-82. PubMed ID: 19935806
[TBL] [Abstract][Full Text] [Related]
58. Distinct pathways for constitutive endocytosis of fully conformed and non-conformed L(d) molecules.
Mahmutefendić H; Kucić N; Lucin P
Am J Reprod Immunol; 2002 Aug; 48(2):87-95. PubMed ID: 12389597
[TBL] [Abstract][Full Text] [Related]
59. The Carboxy Terminus of the Ligand Peptide Determines the Stability of the MHC Class I Molecule H-2Kb: A Combined Molecular Dynamics and Experimental Study.
Abualrous ET; Saini SK; Ramnarayan VR; Ilca FT; Zacharias M; Springer S
PLoS One; 2015; 10(8):e0135421. PubMed ID: 26270965
[TBL] [Abstract][Full Text] [Related]
60. Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes.
Ninkovic T; Kinarsky L; Engelmann K; Pisarev V; Sherman S; Finn OJ; Hanisch FG
Mol Immunol; 2009 Nov; 47(1):131-40. PubMed ID: 19007994
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
